Medicines production

The effectiveness of "Sputnik V" against the Indian strain is about 90%, said Denis Logunov, deputy director of the Gamaleya Center for Research, which developed the vaccine.

A variety of rumors are circulating on social networks related to the coronavirus vaccine and its consequences.

The KoviVac vaccine has ended again in Moscow, medical institutions are waiting for a new supply from the Ministry of Health, according to the website of the mayor and the government of the capital.

At the Chumakov Center of the Russian Academy of Sciences, they are checking how the KoviVac vaccine they have developed copes with new mutations of the coronavirus, in particular with the Indian strain (the delta strain according to the WHO classification)

The vaccine "KoviVac", developed by the Chumakov Center of the Russian Academy of Sciences, has ended in Moscow, the registration for vaccination with this drug has been suspended.

The Russian Direct Investment Fund (RDIF) plans to offer manufacturers a vaccine adapted to the Indian strain of the coronavirus.

In Greece, 40-year-old stylist Nasos Katris died the next day after being vaccinated with AstraZeneca, writes the newspaper "Naftemporiki".

Vietnamese President Nguyen Xuan Phuc on Wednesday sent a letter to Russian leader Vladimir Putin, in which he asked to establish the production of vaccines in the Russian Federation in Vietnam.

On May 25, the Russian Ministry of Health registered the inhaled drug Leitragin for the treatment and prevention of pneumonia, which complicates the course of coronavirus infection.

The Russian Sputnik V coronavirus vaccine may begin to be produced in two more states. This is reported by Vesti.ru.

The EU intends to donate at least 100 million doses of coronavirus vaccines to the poorest countries by the end of 2021.

According to the director of the Russian Foreign Intelligence Service, registration of the Russian vaccine "Sputnik V" in Europe is being delayed at the behest of the high offices of the European Union.

The Indonesian Ministry of Health has suspended the distribution of about 450,000 doses of the AstraZeneca coronavirus vaccine after the death of one of the patients 11 days after vaccination.

Brazil's national regulator Anvisa said it had sent to the country's Supreme Court a list of documents required to make a decision on the import of the Russian Sputnik V coronavirus vaccine.

Hungary became the first European country to receive the entire volume of Sputnik V vaccines under a contract with Russia.